Mereo BioPharma Group plc (MREO)

Stock chart
Ticker: MREO


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Earnings
Earnings
 
Value bought

Past 90 days

 
Value sold

Past 90 days

 
Net insiders buying

Past 90 days

 
Trades (buy and sell)

Past 90 days

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2024-09-16 2024-09-13 S Sale

Sermon Charles

General Counsel

Officer
20,946 -8.7%
4.22
USD 88,413
20,946 -8.7% 4.22 USD 88,413
2024-09-16 2024-09-13 S Sale

Fox Christine Ann

Chief Financial Officer

Officer
19,158 -17.7%
4.22
USD 80,866
19,158 -17.7% 4.22 USD 80,866
2024-09-16 2024-09-13 S Sale

Lewicki John A.

Chief Scientific Officer

Officer
10,937 -12.2%
4.22
USD 46,165
10,937 -12.2% 4.22 USD 46,165
2024-09-16 2024-09-13 S Sale

Scots-Knight Denise

Chief Executive Officer

Executive Director
60,046 -6.9%
4.22
USD 253,454
60,046 -6.9% 4.22 USD 253,454
2024-09-16 2024-09-13 S Sale

Hughes-Wilson Alexandra

See Remarks

Officer
84,008 -62.5%
4.22
USD 354,598
84,008 -62.5% 4.22 USD 354,598
2024-09-16 2024-09-13 S Sale

Hughes-Wilson Alexandra

See Remarks

Officer
16,304 -10.8%
4.22
USD 68,819
16,304 -10.8% 4.22 USD 68,819
2024-09-16 2024-09-12 S Sale

Sermon Charles

General Counsel

Officer
9,980 -4.0%
4.47
USD 44,638
9,980 -4.0% 4.47 USD 44,638
2024-09-16 2024-09-12 S Sale

Fox Christine Ann

Chief Financial Officer

Officer
9,128 -7.8%
4.47
USD 40,827
9,128 -7.8% 4.47 USD 40,827
2024-09-16 2024-09-12 S Sale

Lewicki John A.

Chief Scientific Officer

Officer
5,212 -5.5%
4.47
USD 23,312
5,212 -5.5% 4.47 USD 23,312
2024-09-16 2024-09-12 S Sale

Scots-Knight Denise

Chief Executive Officer

Executive Director
28,611 -3.2%
4.47
USD 127,968
28,611 -3.2% 4.47 USD 127,968
2024-09-16 2024-09-12 S Sale

Hughes-Wilson Alexandra

See Remarks

Officer
40,029 -21.0%
4.47
USD 179,038
40,029 -21.0% 4.47 USD 179,038
2024-09-16 2024-09-12 S Sale

Hughes-Wilson Alexandra

See Remarks

Officer
7,769 -3.9%
4.47
USD 34,748
7,769 -3.9% 4.47 USD 34,748
2024-08-23 2024-08-22 S Sale

PAKIANATHAN DEEPIKA

Non-Executive Director
105,244 -100.0%
4.43
USD 466,210
105,244 -100.0% 4.43 USD 466,210
2024-06-27 2024-06-26 S Sale

Sermon Charles

General Counsel

Officer
32,187 -14.9%
3.39
USD 109,217
32,187 -14.9% 3.39 USD 109,217
2024-06-27 2024-06-26 S Sale

Lewicki John A.

Chief Scientific Officer

Officer
16,808 -25.6%
3.39
USD 57,033
16,808 -25.6% 3.39 USD 57,033
2024-06-27 2024-06-26 S Sale

Hughes-Wilson Alexandra

See Remarks

Officer
22,968 -39.9%
3.39
USD 77,935
22,968 -39.9% 3.39 USD 77,935
2024-06-27 2024-06-26 S Sale

Fox Christine Ann

Chief Financial Officer

Officer
29,439 -33.8%
3.39
USD 99,892
29,439 -33.8% 3.39 USD 99,892
2024-06-27 2024-06-26 S Sale

Scots-Knight Denise

Chief Executive Officer

Executive Director
92,273 -11.5%
3.39
USD 313,101
92,273 -11.5% 3.39 USD 313,101
2024-06-27 2024-06-25 S Sale

Sermon Charles

General Counsel

Officer
14,202 -6.2%
3.69
USD 52,461
14,202 -6.2% 3.69 USD 52,461
2024-06-27 2024-06-25 S Sale

Lewicki John A.

Chief Scientific Officer

Officer
7,416 -10.2%
3.69
USD 27,394
7,416 -10.2% 3.69 USD 27,394
2024-06-27 2024-06-25 S Sale

Hughes-Wilson Alexandra

See Remarks

Officer
10,134 -15.0%
3.69
USD 37,434
10,134 -15.0% 3.69 USD 37,434
2024-06-27 2024-06-25 S Sale

Fox Christine Ann

Chief Financial Officer

Officer
12,990 -13.0%
3.69
USD 47,984
12,990 -13.0% 3.69 USD 47,984
2024-06-27 2024-06-25 S Sale

Scots-Knight Denise

Chief Executive Officer

Executive Director
40,712 -4.8%
3.69
USD 150,386
40,712 -4.8% 3.69 USD 150,386
2024-05-23 2024-05-22 S Sale

Hughes-Wilson Alexandra

See Remarks

Officer
50,082 -60.6%
2.94
USD 147,241
50,082 -60.6% 2.94 USD 147,241
2024-05-23 2024-05-22 S Sale

Hughes-Wilson Alexandra

See Remarks

Officer
50,350 -46.2%
2.99
USD 150,547
50,350 -46.2% 2.99 USD 150,547
// ... existing code ... // ... rest of the file ...